Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription


1 Clin Infect Dis
2 J Infect Dis
2 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
1 Pediatr Infect Dis J
6 PLoS One
1 Proc Natl Acad Sci U S A
17 Vaccine
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. DAUBY N, Gagneux-Brunon A, Martin C, Mussi-Pinhata MM, et al
    Maternal immunization in women living with HIV.
    AIDS. 2024;38:137-144.
    PubMed         Abstract available

    Clin Infect Dis

  2. TADESSE BT, Keddy KH, Rickett NY, Zhusupbekova A, et al
    Vaccination to Reduce Antimicrobial Resistance Burden-Data Gaps and Future Research.
    Clin Infect Dis. 2023;77.
    PubMed         Abstract available

    J Infect Dis

  3. YAMAMOTO S, Matsuda K, Maeda K, Horii K, et al
    Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched Analysis.
    J Infect Dis. 2023;228:1652-1661.
    PubMed         Abstract available

  4. PENETRA SLS, Santos HFP, Resende PC, Bastos LS, et al
    SARS-CoV-2 Reinfection Cases in a Household-Based Prospective Cohort in Rio de Janeiro.
    J Infect Dis. 2023;228:1680-1689.
    PubMed         Abstract available


  5. RUBIN R
    Despite Safe and Effective Vaccine, Measles Cases and Deaths Increased Worldwide From 2021 to 2022.
    JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25527.

    MMWR Morb Mortal Wkly Rep

  6. BLACK CL, Kriss JL, Razzaghi H, Patel SA, et al
    Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1377-1382.
    PubMed         Abstract available

  7. RESES HE, Dubendris H, Haas L, Barbre K, et al
    Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, December 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1371-1376.
    PubMed         Abstract available

    N Engl J Med

  8. COHN AC, Hall AJ
    Continued Progress in the Development of Safe and Effective RSV Immunizations.
    N Engl J Med. 2023;389:2289-2290.

    Pediatr Infect Dis J

  9. RYBAK A, Ouldali N, Varon E, Taha MK, et al
    Vaccine-preventable Pediatric Acute Bacterial Meningitis in France: A Time Series Analysis of a 19-Year Prospective National Surveillance Network.
    Pediatr Infect Dis J. 2024;43:74-83.
    PubMed         Abstract available

    PLoS One

  10. FARRENKOPF BA, Zhou X, Shet A, Olayinka F, et al
    Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.
    PLoS One. 2023;18:e0287459.
    PubMed         Abstract available

  11. MACGREGOR-FAIRLIE M, De Gomes P, Weston D, Rickard JJS, et al
    Hybrid use of Raman spectroscopy and artificial neural networks to discriminate Mycobacterium bovis BCG and other Mycobacteriales.
    PLoS One. 2023;18:e0293093.
    PubMed         Abstract available

  12. BIRHANU F, Yitbarek K
    Wealth-based inequity in full child vaccination coverage: An experience from Mali, Bangladesh, and South Africa. A multilevel poison regression.
    PLoS One. 2023;18:e0293522.
    PubMed         Abstract available

  13. PATWARY MM, Disha AS, Hasan M, Bardhan M, et al
    Integrating health belief model and theory of planned behavior to assess COVID-19 vaccine acceptance among urban slum people in Bangladesh.
    PLoS One. 2023;18:e0290412.
    PubMed         Abstract available

  14. KRASTEV S, Krajden O, Vang ZM, Perez-Gay Juarez F, et al
    Navigating the uncertainty: A novel taxonomy of vaccine hesitancy in the context of COVID-19.
    PLoS One. 2023;18:e0295912.
    PubMed         Abstract available

  15. BRODY C, Szieff J, Abu-Alrub B
    "If it wasn't forced upon me, I would have given it a second thought": Understanding COVID-19 vaccine hesitancy in an outlier county in the Bay Area, California.
    PLoS One. 2023;18:e0290469.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  16. RAO X, Zhao R, Tong Z, Guo S, et al
    Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2314193120.
    PubMed         Abstract available


  17. JORDAN Z, Rowland E
    Parental perceptions of chickenpox and the varicella vaccine: A qualitative systematic review.
    Vaccine. 2023 Dec 20:S0264-410X(23)01491-3. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  18. KURIYAMA K, Murakami K, Sugiura K, Sakui S, et al
    Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial.
    Vaccine. 2023 Dec 20:S0264-410X(23)01482-2. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  19. LINK-GELLES R, Britton A, Fleming-Dutra KE
    Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions.
    Vaccine. 2023 Dec 20:S0264-410X(23)01435-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  20. WOLFF M, Charpentier P, Canals A, Vial C, et al
    Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study.
    Vaccine. 2023 Dec 19:S0264-410X(23)01481-0. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  21. LYU Y, Choong A, Chow EPF, Seib KL, et al
    Vaccine value profile for Neisseria gonorrhoeae.
    Vaccine. 2023 Dec 13:S0264-410X(23)00086-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  22. STUMPF J, Anders L, Siepmann T, Schwobel J, et al
    9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patients.
    Vaccine. 2023 Dec 18:S0264-410X(23)01479-2. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  23. ARASHIRO T, Miwa M, Nakagawa H, Takamatsu J, et al
    COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study).
    Vaccine. 2023 Dec 18:S0264-410X(23)01480-9. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  24. PILIOU S, Farman TA, Marini A, Manoharan S, et al
    Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system.
    Vaccine. 2023;41:7671-7681.
    PubMed         Abstract available

  25. VASHI MD, Watkins M
    Missed opportunities: Reducing zero dose children amongthe urban poor after COVID, Mumbai India, 2022.
    Vaccine. 2024;42:59-63.
    PubMed         Abstract available

  26. DE PINHO RB, Barbosa TN, Dall'Agno L, da Rocha Fonseca B, et al
    Mycobacterium bovis BCG expressing the proteins CP40 or CP09720 of Corynebacterium pseudotuberculosis promotes protection in mice after challenge.
    Vaccine. 2024;42:33-39.
    PubMed         Abstract available

  27. BURNS KE, Dube E, Godinho Nascimento H, Meyer SB, et al
    Examining vaccine hesitancy among a diverse sample of Canadian adults.
    Vaccine. 2023 Dec 15:S0264-410X(23)01476-7. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  28. JIANG W, Lu C, Yan X, Tucker JD, et al
    Vaccine confidence mediates the association between a pro-social pay-it-forward intervention and improved influenza vaccine uptake in China: A mediation analysis.
    Vaccine. 2023 Dec 15:S0264-410X(23)01392-0. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  29. BAJRACHARYA D, Jansen RJ
    Observations of COVID-19 vaccine coverage and vaccine hesitancy on COVID-19 outbreak: An American ecological study.
    Vaccine. 2023 Dec 15:S0264-410X(23)01441-X. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  30. ZHAN XY, Chen Y, Zhang X, Shi Q, et al
    Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination.
    Vaccine. 2023 Dec 15:S0264-410X(23)01465-2. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  31. JACKSON LA, Stapleton JT, Walter EB, Chen WH, et al
    Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults.
    Vaccine. 2023 Dec 16:S0264-410X(23)01434-2. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  32. PICHON S, Moureau A, Petit C, Kirstein JL, et al
    Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax(R) Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.
    Vaccine. 2023 Dec 16:S0264-410X(23)01398-1. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  33. DAWA J, Jalang'o R, Mirieri H, Kalani R, et al
    Comparing performance of year-round and campaign-mode influenza vaccination strategies among children aged 6-23 months in Kenya: 2019-2021.
    Vaccine. 2023 Dec 16:S0264-410X(23)01380-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

    Virus Res

  34. DESMET C, Coelho-Cruz B, Mehn D, Colpo P, et al
    ASFV epitope mapping by high density peptides microarrays.
    Virus Res. 2024;339:199287.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.